2seventy bio, Inc.
TSVT
$4.99
-$0.01-0.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 683.94% | -78.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 683.94% | -78.38% | |||
| Cost of Revenue | -39.69% | 24.19% | |||
| Gross Profit | 185.01% | -2,529.96% | |||
| SG&A Expenses | 74.20% | -33.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.38% | -3.53% | |||
| Operating Income | 89.33% | -71.86% | |||
| Income Before Tax | 102.47% | -96.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 102.47% | -96.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 102.47% | -96.52% | |||
| EBIT | 89.33% | -71.86% | |||
| EBITDA | 96.15% | -81.99% | |||
| EPS Basic | 102.44% | -96.21% | |||
| Normalized Basic EPS | 102.73% | -104.88% | |||
| EPS Diluted | 102.44% | -96.21% | |||
| Normalized Diluted EPS | 102.73% | -104.88% | |||
| Average Basic Shares Outstanding | 1.38% | 0.14% | |||
| Average Diluted Shares Outstanding | 2.10% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||